Tarsus Pharmaceuticals (TARS) Finished Goods (2023 - 2026)
Tarsus Pharmaceuticals (TARS) posted quarterly Finished Goods of $2.9 million for Q1 2026, up 51.47% year-over-year from $1.9 million in Q1 2025, and down 0.74% quarter-over-quarter from $3.0 million in Q4 2025.
Tarsus Pharmaceuticals (TARS) Finished Goods (2023 - 2026) Analysis & Trends
Tarsus Pharmaceuticals' Finished Goods history runs 4 years deep, the most recent figure standing at $2.9 million for Q1 2026.
- In Q1 2026, Finished Goods rose 51.47% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (up 51.47% YoY), while the FY2025 annual figure was $3.0 million, up 47.66% from the prior year.
- Finished Goods for Q1 2026 stood at $2.9 million, down from $3.0 million in the prior quarter.
- The five-year high for Finished Goods was $3.0 million in Q4 2025, with the low at $182000.0 in Q4 2023.
- The 4-year median for Finished Goods is $2.0 million (2024), against an average of $1.8 million.
- The sharpest annual moves came in 2024 and 2025: Finished Goods surged 1002.2% in 2024, then jumped 47.66% in 2025.
- Tarsus Pharmaceuticals' Finished Goods stood at $182000.0 in 2023, then soared by 1002.2% to $2.0 million in 2024, then soared by 47.66% to $3.0 million in 2025, then decreased by 0.74% to $2.9 million in 2026.
- Business Quant data shows TARS's Finished Goods at $2.9 million in Q1 2026, $3.0 million in Q4 2025, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tarsus Pharmaceuticals | 2.99 Bn | 2.54 Bn | 161.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.02 Mn |
| Mar 31, 2026 | 2.94 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Sep 30, 2025 | 2.84 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Mar 31, 2025 | 1.94 Mn |
| Dec 31, 2024 | 2.01 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 826,000.00 |
| Dec 31, 2023 | 182,000.00 |